XPHOZAH is the first and only phosphate absorption inhibitor (PAI) approved by the U.S. Food and Drug Administration to reduce serum phosphorus in adults with chronic kidney disease on dialysis as add ...
Chronic kidney disease develops silently. Kidneys filter waste, but when they weaken, toxins build up. This impacts the heart, bones, and blood. Early detection is crucial. Managing blood pressure and ...
From ESS News China Petroleum & Chemical Corporation (Sinopec) and South Korea’s LG Chem have signed a joint development agreement to advance key materials for sodium-ion batteries, as the technology ...
Eye-specific differences in presynaptic release site addition and clustering correlate with axonal segregation outcomes during retinogeniculate refinement in the mouse.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback